For bile duct carcinoma, it was found that the knockdown of claudin-18 expression or an antibody specific to claudin-18 can significantly attenuate the proliferation, invasion and in vivo tumourigenesis of bile duct adenocarcinoma cells. The gene discussed is CLDN18; the disease is bile duct adenocarcinoma.